BIANCHI, Roberta
 Distribuzione geografica
Continente #
NA - Nord America 2.587
EU - Europa 2.157
AS - Asia 768
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
Totale 5.534
Nazione #
US - Stati Uniti d'America 2.581
IT - Italia 484
IE - Irlanda 393
UA - Ucraina 390
SE - Svezia 288
SG - Singapore 273
HK - Hong Kong 183
VN - Vietnam 136
CN - Cina 129
RO - Romania 111
DE - Germania 109
FI - Finlandia 99
FR - Francia 86
RU - Federazione Russa 71
GB - Regno Unito 31
CZ - Repubblica Ceca 29
BE - Belgio 24
CH - Svizzera 15
CI - Costa d'Avorio 14
GR - Grecia 11
TR - Turchia 11
UZ - Uzbekistan 9
KR - Corea 8
IN - India 7
NL - Olanda 7
LB - Libano 6
AT - Austria 4
EU - Europa 4
MX - Messico 4
BR - Brasile 2
CA - Canada 2
PL - Polonia 2
HU - Ungheria 1
JP - Giappone 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
NG - Nigeria 1
PH - Filippine 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.534
Città #
Chandler 427
Dublin 393
Perugia 282
San Mateo 232
Singapore 231
Jacksonville 191
Hong Kong 183
Boardman 157
Dong Ket 135
Santa Clara 113
Bucharest 111
Wilmington 97
Medford 94
Princeton 93
Altamura 89
Redmond 89
Ann Arbor 77
Andover 70
Des Moines 69
Lawrence 68
Beijing 56
Falls Church 45
Dearborn 34
Woodbridge 27
Pisa 26
Saint Petersburg 26
Brussels 24
Ashburn 23
Norwalk 22
Brno 18
Fremont 16
New York 16
Abidjan 14
Helsinki 14
San Paolo di Civitate 14
Dallas 12
Munich 11
Izmir 10
Los Angeles 9
Olomouc 9
San Diego 9
Seoul 7
Den Haag 6
Hanover 6
Moscow 6
Shanghai 6
Milan 5
Nanjing 5
Redwood City 5
Nagpur 4
Tappahannock 4
Auburn Hills 3
Chengdu 3
Chicago 3
Frankfurt Am Main 3
Jinan 3
Nichelino 3
Nürnberg 3
Paris 3
Spoleto 3
Cambridge 2
Edinburgh 2
Guangzhou 2
Handan 2
Houston 2
Kunming 2
Lausanne 2
Ludwigshafen 2
Nanchang 2
Planegg 2
Pune 2
Rio De Janeiro 2
Saint Louis 2
San Jose 2
Shenyang 2
Silea 2
Terni 2
Vicenza 2
Wuhan 2
Zhengzhou 2
Athens 1
Azcapotzalco 1
Bishkek 1
Boston 1
Bratislava 1
Budapest 1
Cagliari 1
Carrollton 1
Castel Maggiore 1
Civitanova Marche 1
Dalian 1
Dambulla 1
Denver 1
Fairfield 1
Freiburg 1
Gaziantep 1
Genova 1
Kraków 1
Lagos 1
Lappeenranta 1
Totale 3.777
Nome #
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 139
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 130
A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression. 128
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 128
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 124
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 122
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 119
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 112
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 107
IL‐35Ig–expressing dendritic cells induce tolerance via Arginase 1 105
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 92
The TGF-β/IDO axis in infectious tolerance. 90
A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815. 88
87P - Towards the identification of the mechanism of action of antitumor 1-methyl-D-tryptophan 87
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 86
CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide 85
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 85
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 85
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 84
Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis 81
CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice 80
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 80
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level. 80
Antigen-specific immunoregulation by IL-35Ig-transfected dendritic cells 76
IL-12 acts selectively on CD8a- dendritic cells to enhance presentation of a tumor peptide in vivo 75
Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. 75
Adoptive immunotherapy of intracerebral murine lymphomas: role of different lymphoid populations. 74
Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation 73
Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells. 72
Modulation of tryptophan catabolism by regulatory T cells 69
Ectopic expression of IL-35Ig by dendritic cells induces tolerance via Arginase 1. 69
O6-alkylguanine-DNA alkyltransferase attenuates triazene-induced cytotoxicity and tumor cell immunogenicity in murine L1210 leukemia 68
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. 66
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 66
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 65
[Experimental models of immunochemotherapeutic synergism: study of the influence of the treatment schedule]. 62
Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. 61
Drug-induced immunogenic changes of murine leukemia cells: dissociation of onset of resistance and emergence of novel immunogenicity. 60
Systemic adoptive immunotherapy of a highly immunogenic murine lymphoma growing in the brain. 58
CD40 ligand and CTLA-4 are reciprocally regulated in the Th1 cell proliferative response sustained by CD8+ dendritic cells. 57
T cell apoptosis by tryptophan catabolism 56
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 56
Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine 55
A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state 55
Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. 55
Immunobiological aspects of the nude mouse model relative to human cancer chemosensitivity tests. 55
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 55
IL-12 is both required and sufficient for initiating T-cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells 55
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 55
Immunomodulatory properties of ribavirin in the mouse. 54
[Transfer in vivo of cytotoxic immune lymphocytes obtained in vitro in primary culture against a murine lymphoma antigenically altered by DTIC]. 54
Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization. 53
CTLA-4-Ig regulates tryptophan catabolism in vivo. 52
Towards the identification of a tolerogenic signature in IDO-competent dendritic cells 52
CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig. 52
Tumor-specific L3T4+ and Lyt-2+ lymphocytes in mice primed to mutagenized cell variants. 51
Immunogenic properties of retroviral protein p15E from drug-treated murine mastocytoma P815 50
Dendritic cells, CD4+ lymphocytes and IL-12 in an experimental model of antitumor immunotherapy 50
Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12 50
IL-12 ACTS DIRECTLY ON DC TO PROMOTE NUCLEAR LOCALIZATION OF NF-kB AND PRIMES DC FOR IL-12 PRODUCTION 50
Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. 49
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 48
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells 47
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. 47
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells 46
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 45
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice 45
O6-methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents. 43
Molecular and genomic aspects of xenogenizing-alkylating drugs. 43
Use of a skin test assay to determine tumor-specific CD8+ T cell reactivity 42
IL-23 and IL-12 have overlapping but distinct effects on murine dendritic cells. 42
Dendritic cells and interleukin 12 as adjuvants for tumor-specific vaccines. 41
Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement 41
Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. 40
IL-12 induces SDS-stable class II (alpha beta) dimers in murine dendritic cells 40
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 40
Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma 39
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. 39
Intracerebral adoptive immunotherapy of a murine lymphoma antigenically altered by drug treatment in vivo. 39
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 39
Tryptophan catabolism generates autoimmune-preventive regulatory T cells 38
Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex 38
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 37
Indoleamine 2,3-dioxygenase: from catalyst to signaling function 36
Tryptophan catabolism in nonobese diabetic mice. 36
Inhibition of murine lymphoma growth by adoptive transfer of lymphocytes sensitized to a xenogenized tumor variant. 35
Induction of tumor suppression and delayed-type footpad reaction by transfer of lymphocytes sensitized to a xenogenized tumor variant. 32
PROTEASOME INHIBITION IN pDCs CONFERS AN IDO-DEPENDENT IMMUNOREGULATORY PHENOTYPE 29
IDO-TARGETING INTERVENTION IN AUTOIMMUNE DIABETES BY PROTEASOME INHIBITION 27
IFN-gamma inhibits presentation of a tumor/self peptide by CD8 alpha- dendritic cells via potentation of the CD8 alpha+ subset 26
Th1 and Th2 cell clones to poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo 25
The role of IL-12 in the induction of an immune response to a tumor/self peptide: prevention and reversion of anergy. 24
Indoleamine 2,3 dioxygnenase: as an inducer and amplifier of regulatory T cell functions. 23
Totale 5.789
Categoria #
all - tutte 23.065
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.065


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020391 0 0 0 0 0 36 85 20 109 56 23 62
2020/2021978 6 59 33 59 285 68 93 5 109 41 69 151
2021/20221.141 15 160 12 52 56 32 14 277 108 88 107 220
2022/20231.462 107 249 15 116 137 187 0 77 515 5 41 13
2023/2024559 35 85 15 9 3 9 150 17 50 12 63 111
2024/2025525 23 113 98 72 160 59 0 0 0 0 0 0
Totale 5.789